Didier Tchétché

Showing 1-20 of 22 articles

TAV-in-TAV for failed prosthesis: the new frontier

June 12, 2020 | 10.4244/EIJV16I2A15

Interventions for valvular disease

Transcatheter mitral valve replacement: factors associated with screening success and failure

Coisne A, Pontana F, Tchétché D, Richardson M, Longère B, Vahdat O, Berthoumieu P, Van Belle E, Rousse N, Lancellotti P, Montaigne D, Dumonteil N, Modine T

December 6, 2019 | 10.4244/EIJ-D-19-00444

Improving our knowledge about a new plug-based vascular closure device

Tchétché D

May 20, 2019 | 10.4244/EIJV15I1A4

TAVI and the brain: update on definitions, evidence of neuroprotection and adjunctive pharmacotherapy

Lansky A, Ghare M, Tchétché D, Baumbach A

September 7, 2018 | 10.4244/EIJ-D-18-00454

Interventions for valvular disease

Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve

Kim U, Blanke P, Windecker S, Kasel A, Schäfer U, Walters D, Linke A, Le Breton H, Schymik G, Spence M, Søndergaard L, Abdel-Wahab M, Worthley S, Tchétché D, Reichenspurner H, Ohana M, Sellers S, Leipsic J

August 3, 2018 | 10.4244/EIJ-D-17-01040

Interventions for valvular disease

Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients

Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K

September 20, 2017 | 10.4244/EIJ-D-16-01024

Interventions for valvular disease

Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort

Dumonteil N, Meredith I, Blackman D, Tchétché D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Houle V, Allocco D, Dawkins K

September 20, 2017 | 10.4244/EIJ-D-16-01025

Interventions for valvular disease

The SURTAVI study: TAVI for patients with intermediate risk

Jones D, Tchétché D, Forrest J, Hellig F, Lansky A, Moat N

August 4, 2017 | 10.4244/EIJV13I5A97

Interventions for valvular disease

How should I treat a patient with a symptomatic and severe low-flow low-gradient aortic stenosis and an incidental abdominal aortic aneurysm?

Rahhab Z, Raa S, van der Ploeg N, Van Mieghem N, Verhagen H, de Jaegere P, Arsalan M, Kim W, Walther T, Tchétché D

July 20, 2017 | 10.4244/EIJ-D-16-00461

Interventions for valvular disease

Annulus rupture post transcatheter aortic valve implantation complicated by a giant pseudoaneurysm

Thimon T, Molina-Martin de Nicolas J, Lapeyre M, Tchétché D

February 3, 2017 | 10.4244/EIJ-D-16-00347

Interventions for valvular disease

A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis

Naber C, Pyxaras S, Ince H, Frambach P, Colombo A, Butter C, Gatto F, Hink U, Nickenig G, Bruschi G, Brueren G, Tchétché D, den Heijer P, Schillinger W, Scholtz S, Van der Heyden J, Lefèvre T, Gilard M, Kuck K, Schofer J, Divchev D, Baumgartner H, Asch F, Wagner M, Latib A, De Marco F, Kische S

December 9, 2016 | 10.4244/EIJ-D-15-00511

Interventions for valvular disease

Impact of permanent pacemaker on mortality after transcatheter aortic valve implantation: the PRAGMATIC (Pooled Rotterdam-Milan-Toulouse in Collaboration) Pacemaker substudy

Giustino G, van der Boon R, Molina-Martin de Nicolas J, Dumonteil N, Chieffo A, de Jaegere P, Tchétché D, Marcheix B, Millischer D, Cassagneau R, Carrié D, Van Mieghem N, Colombo A

October 20, 2016 | 10.4244/EIJV12I9A192

Interventions for valvular disease

Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 1: systematic measurement methodology and inter-observer variability

Thériault-Lauzier P, Mylotte D, Dorfmeister M, Spaziano M, Andalib A, Mamane S, Chetrit M, Blanke P, Cecere R, Buithieu J, Martucci G, Tchétché D, Modine T, Van Mieghem N, Lange R, Windecker S, Bilodeau L, Leipsic J, Piazza N

October 10, 2016 | 10.4244/EIJY15M11_09

Interventions for valvular disease

In vitro evaluation of implantation depth in valve-in-valve using different transcatheter heart valves

Simonato M, Azadani A, Webb J, Leipsic J, Kornowski R, Vahanian A, Wood D, Piazza N, Kodali S, Ye J, Whisenant B, Gaia D, Aziz M, Pasala T, Mehilli J, Wijeysundera H, Tchétché D, Moat N, Teles R, Petronio A, Hildick-Smith D, Landes U, Windecker S, Arbel Y, Mendiz O, Makkar R, Tseng E, Dvir D

September 18, 2016 | 10.4244/EIJV12I7A149

Interventions for valvular disease

TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery

van Gils L, Tchétché D, Latib A, Sgroi C, Manoharan G, Möllmann H, Van Mieghem N

September 18, 2016 | 10.4244/EIJV12SYA6

Interventions for valvular disease

Current decision making and short-term outcome in patients with degenerative aortic stenosis: the Pooled-RotterdAm-Milano-Toulouse In Collaboration Aortic Stenosis survey

Van Mieghem N, Dumonteil N, Chieffo A, Roux Y, van der Boon R, Giustino G, Hartman E, Aga Y, de Jong L, Ghanem M, Marcheix B, Cavazza C, Carrié D, Colombo A, Kappetein A, de Jaegere P, Tchétché D

February 12, 2016 | 10.4244/EIJV11I10A253

Interventions for valvular disease

Edwards SAPIEN 3 implanted in a failing aortic bioprosthesis: first report

Molina-Martin de Nicolas J, Tchétché D, Farah B

February 12, 2016 | 10.4244/EIJV11I11A255

New-generation TAVI devices: description and specifications

Tchétché D, Van Mieghem N

September 27, 2014 | 10.4244/EIJV10SUA13

How should I treat a patient with symptomatic severe aortic stenosis and a 23 mm aortic annulus who is referred for transcatheter aortic valve replacement using the CoreValve prosthesis?

Ko B, Antonis P, Meredith I, Tchétché D, Eggebrecht H, Zierer A, Doss M

February 22, 2013 | 10.4244/EIJV8I10A186

Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system

Tchétché D, Modine T, Farah B, Vahdat O, Sudre A, Koussa M, Lereun C, Nejjari M, Choby M, Rosencher J, Sorbets E, Fajadet J

September 28, 2012 | 10.4244/EIJV8I5A86

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

News

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

March 4, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

March 2, 2021

Guidance Papers

Guidelines, consensus & position papers